A common genetic network underlies substance use disorders and disruptive or externalizing disorders

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  H. Hakonarson,et al.  A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD , 2011, Molecular Psychiatry.

[3]  S. Cichon,et al.  Genome‐wide association study in German patients with attention deficit/hyperactivity disorder , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[5]  R. Spritz.  Recent progress in the genetics of generalized vitiligo. , 2011, Journal of genetics and genomics = Yi chuan xue bao.

[6]  F. Lopera,et al.  Potential cognitive endophenotypes in multigenerational families: segregating ADHD from a genetic isolate , 2011, Attention deficit and hyperactivity disorders.

[7]  M. Arcos-Burgos,et al.  A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome , 2011, Translational Psychiatry.

[8]  C. Hoggart,et al.  TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 Influence Different Pathways Leading to Smoking Behavior from Adolescence to Mid-Adulthood , 2011, Biological Psychiatry.

[9]  B. Franke,et al.  Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. , 2011, The American journal of psychiatry.

[10]  M. Bayés,et al.  Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study , 2011, Genes, brain, and behavior.

[11]  L. Kiemeney,et al.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. , 2011, The New England journal of medicine.

[12]  M. Muenke,et al.  From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein‐coupled receptors, are implicated in psychiatric disorders , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  J. Anaya.  The autoimmune tautology , 2010, Arthritis Research & Therapy.

[14]  C. Freitag,et al.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. , 2010, Molecular psychiatry.

[15]  M. Muenke,et al.  Toward a better understanding of ADHD: LPHN3 gene variants and the susceptibility to develop ADHD , 2010, Attention deficit and hyperactivity disorders.

[16]  M. Daly,et al.  Case-control genome-wide association study of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[17]  Jo Lambert,et al.  Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. , 2010, The New England journal of medicine.

[18]  P. Zandi,et al.  Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. , 2010, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[19]  G. Salmon,et al.  Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.

[20]  R. Perou,et al.  Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. , 2010, MMWR. Morbidity and mortality weekly report.

[21]  M. Muenke,et al.  ADHD latent class clusters: DSM-IV subtypes and comorbidity , 2009, Psychiatry Research.

[22]  S. Pliszka,et al.  Attention‐Deficit‐Hyperactivity Disorder: An Update , 2009, Pharmacotherapy.

[23]  Margit Burmeister,et al.  New insights into the genetics of addiction , 2009, Nature Reviews Genetics.

[24]  Hongyu Zhao,et al.  Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. , 2008, Alcoholism, clinical and experimental research.

[25]  M. Iyo,et al.  Genome-wide association for methamphetamine dependence: convergent results from 2 samples. , 2008, Archives of general psychiatry.

[26]  O. Bukstein.  Substance abuse in patients with attention-deficit/hyperactivity disorder. , 2008, Medscape journal of medicine.

[27]  G. Uhl,et al.  "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. , 2008, Biochemical pharmacology.

[28]  Hongyu Zhao,et al.  Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. , 2007, Human molecular genetics.

[29]  L. Rohde,et al.  Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study. , 2007, Addiction.

[30]  F. Castellanos,et al.  Attention-Deficit/Hyperactivity Disorder and Comorbid Disruptive Behavior Disorders: Evidence of Pleiotropy and New Susceptibility Loci , 2007, Biological Psychiatry.

[31]  W. Pelham,et al.  The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. , 2007, Journal of pediatric psychology.

[32]  K. Brady,et al.  Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. , 2006, Human molecular genetics.

[33]  Tomas Drgon,et al.  Addiction molecular genetics: 639,401 SNP whole genome association identifies many “cell adhesion” genes , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[34]  Tatiana Foroud,et al.  Pooled association genome scanning for alcohol dependence using 104,268 SNPs: Validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  Joseph Biederman,et al.  Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth , 2006, Journal of psychopharmacology.

[36]  H. Schubiner.  Substance Abuse in Patients with Attention-Deficit Hyperactivity Disorder , 2005, CNS drugs.

[37]  George R. Uhl,et al.  Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process , 2004, Neuropharmacology.

[38]  J. Rapoport,et al.  Attention-deficit/hyperactivity disorder and comorbidities in 18 Paisa Colombian multigenerational families. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[39]  J. Rapoport,et al.  Attention-Deficit/Hyperactivity Disorder in a Population Isolate: Linkage to Loci at 4q13.2, 5q33.3, 11q22, and 17p11 , 2022 .

[40]  G. Uhl.  Molecular Genetics of Substance Abuse Vulnerability: Remarkable Recent Convergence of Genome Scan Results , 2004, Annals of the New York Academy of Sciences.

[41]  S. Acheson,et al.  Predictors of Relapse during Treatment and Treatment Completion among Marijuana-Dependent Adolescents in an Intensive Outpatient Substance Abuse Program , 2004, Substance abuse.

[42]  J. Rapoport,et al.  Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate , 2004, Molecular Psychiatry.

[43]  L. Paquet.  [Economic impact]. , 2004, SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging.

[44]  M. Muenke,et al.  Attention deficit/hyperactivity disorder (ADHD): Complex phenotype, simple genotype? , 2004, Genetics in Medicine.

[45]  W. Pelham,et al.  Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. , 2003, Journal of abnormal psychology.

[46]  H. Coşkunol,et al.  Childhood attention deficit/hyperactivity disorder and alcohol dependence: a 1-year follow-up. , 2003, Alcohol and alcoholism.

[47]  Joseph Biederman,et al.  Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse? , 2003, Pediatrics.

[48]  JaneR . Taylor,et al.  Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. , 2003, The American journal of psychiatry.

[49]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[50]  K. Bucholz,et al.  Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence. , 2001, The American journal of psychiatry.

[51]  D. Naiman,et al.  Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. , 2001, American journal of human genetics.

[52]  K. Kendler,et al.  Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. , 2000, American journal of medical genetics.

[53]  E. Martin,et al.  A test for linkage and association in general pedigrees: the pedigree disequilibrium test. , 2000, American journal of human genetics.

[54]  W. Pelham,et al.  Interactive effects of attention deficit hyperactivity disorder and conduct disorder on early adolescent substance use , 1999 .

[55]  M. Tsuang,et al.  Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. , 1999, American journal of medical genetics.

[56]  A. Goldstein,et al.  A genome‐wide search for loci contributing to smoking and alcoholism , 1999, Genetic epidemiology.

[57]  G. Uhl.  Molecular Genetics of Substance Abuse Vulnerability: A Current Approach , 1999, Neuropsychopharmacology.

[58]  M. Tsuang,et al.  Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. , 1998, Archives of general psychiatry.

[59]  J. Rice,et al.  Genome-wide search for genes affecting the risk for alcohol dependence. , 1998, American journal of medical genetics.

[60]  J. Long,et al.  Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. , 1998, American journal of medical genetics.

[61]  E. Khantzian.  The Self‐Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications , 1997, Harvard review of psychiatry.

[62]  K. Scheibe,et al.  Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[63]  S. Faraone,et al.  Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. , 1995, The American journal of psychiatry.

[64]  L. Demilio,et al.  Psychiatric syndromes in adolescent substance abusers. , 1989, The American journal of psychiatry.

[65]  R. Howard.  The Economic Impact , 1982 .